Protein tyrosine phosphatase non-receptor type 20 (PTPN20)

Protein tyrosine phosphatase non-receptor type 20 (PTPN20) is a cytoplasmic enzyme that belongs to the classical protein tyrosine phosphatase family, involved in the removal of phosphate groups from tyrosine residues on target proteins. Unlike receptor-type PTPs, PTPN20 is not embedded in the cell membrane and thus is distributed in intracellular locations, including sites of actin polymerization, which suggests a role in regulating cytoskeleton dynamics and cell movement. PTPN20 undergoes alternative splicing, generating multiple isoforms with regulatory roles in cell signaling and innate immunity. Current studies indicate that PTPN20 has prognostic value in gastric cancer linked to Helicobacter pylori infection, with its expression patterns correlating with immune infiltration and tumor mutational burden. Its dysregulation has been reported in several other cancers and inflammatory diseases, positioning it as a promising biomarker and potential therapeutic target. However, the precise functions, cellular targets, and broader clinical significance of PTPN20 are still being studied, and its mechanisms in disease contexts remain incompletely defined.

Other names

Tyrosine-protein phosphatase non-receptor type 20PTPN20APTPN20BhPTPN20bA42B19.1DKFZP566K0524bA142I17.1CT126

Proposed mechanisms for drug development or study include modulation of innate immune pathways (e.g., Toll-like receptor signaling), regulation of cell survival and proliferation through phosphatase activity, and impacts on tumor mutation burden and immune cell infiltration (hypothetical mechanism for cancer therapy).